-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Context Capital Management LLC Purchases New Position in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD)
Context Capital Management LLC Purchases New Position in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD)
Context Capital Management LLC acquired a new stake in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 135,339 shares of the company's stock, valued at approximately $1,353,000. Context Capital Management LLC owned approximately 0.48% of Intelligent Medicine Acquisition as of its most recent filing with the SEC.
Other large investors have also bought and sold shares of the company. Wolverine Asset Management LLC purchased a new stake in shares of Intelligent Medicine Acquisition in the 4th quarter worth $99,000. Lynwood Capital Management Inc. bought a new position in shares of Intelligent Medicine Acquisition in the 1st quarter valued at about $315,000. Starboard Value LP bought a new position in shares of Intelligent Medicine Acquisition in the 4th quarter valued at about $952,000. Radcliffe Capital Management L.P. bought a new position in shares of Intelligent Medicine Acquisition in the 4th quarter valued at about $2,970,000. Finally, Beryl Capital Management LLC purchased a new stake in Intelligent Medicine Acquisition in the 4th quarter worth about $5,594,000. 25.60% of the stock is owned by institutional investors.
Get Intelligent Medicine Acquisition alerts:Intelligent Medicine Acquisition Price Performance
Shares of NASDAQ:IQMD opened at $10.06 on Thursday. The firm's 50 day simple moving average is $10.01 and its 200-day simple moving average is $9.98. Intelligent Medicine Acquisition Corp. has a one year low of $9.86 and a one year high of $10.93.
Intelligent Medicine Acquisition Profile
(Get Rating)Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.
Further Reading
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMD)
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
- Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
- The 2 Dow Stocks with Decade-Long Win Streaks on the Line
- Could Rite Aid Be an Acquisition Target, Again?
Want to see what other hedge funds are holding IQMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating).
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Context Capital Management LLC acquired a new stake in shares of Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 135,339 shares of the company's stock, valued at approximately $1,353,000. Context Capital Management LLC owned approximately 0.48% of Intelligent Medicine Acquisition as of its most recent filing with the SEC.
根据上下文资本管理有限公司与纳斯达克的最新披露,该公司在第一季度收购了智能医药收购公司(Temasek Holdings:IQMD-Get Rating)的新股。该基金购买了135,339股该公司的股票,价值约为1,353,000美元。截至最近向美国证券交易委员会提交的文件,Context Capital Management LLC持有智能医药收购约0.48%的股份。
Other large investors have also bought and sold shares of the company. Wolverine Asset Management LLC purchased a new stake in shares of Intelligent Medicine Acquisition in the 4th quarter worth $99,000. Lynwood Capital Management Inc. bought a new position in shares of Intelligent Medicine Acquisition in the 1st quarter valued at about $315,000. Starboard Value LP bought a new position in shares of Intelligent Medicine Acquisition in the 4th quarter valued at about $952,000. Radcliffe Capital Management L.P. bought a new position in shares of Intelligent Medicine Acquisition in the 4th quarter valued at about $2,970,000. Finally, Beryl Capital Management LLC purchased a new stake in Intelligent Medicine Acquisition in the 4th quarter worth about $5,594,000. 25.60% of the stock is owned by institutional investors.
其他大型投资者也买卖了该公司的股票。金刚狼资产管理有限责任公司在第四季度购买了智能医药收购公司价值99,000美元的新股份。林伍德资本管理公司(Lynwood Capital Management Inc.)在第一季度购买了智能医药收购公司的新头寸,价值约315,000美元。Starboard Value LP在第四季度购买了智能医药收购的新头寸,价值约95.2万美元。Radcliffe Capital Management L.P.在第四季度购买了智能医药收购的新头寸,价值约297万美元。最后,贝丽尔资本管理有限责任公司在第四季度购买了智能医疗收购的新股份,价值约559.4万美元。25.60%的股票由机构投资者持有。
Intelligent Medicine Acquisition Price Performance
智能医疗采办性价比
Shares of NASDAQ:IQMD opened at $10.06 on Thursday. The firm's 50 day simple moving average is $10.01 and its 200-day simple moving average is $9.98. Intelligent Medicine Acquisition Corp. has a one year low of $9.86 and a one year high of $10.93.
纳斯达克:iqmd股价周四开盘报10.06美元。该公司的50日简单移动均线切入位为10.01美元,200日简单移动均线切入位为9.98美元。智能医药收购公司的股价一年来最低为9.86美元,一年最高为10.93美元。
Intelligent Medicine Acquisition Profile
智能医疗采集配置文件
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.
智能医药收购公司没有重大业务。公司专注于与一家或多家企业进行合并、资本换股、资产收购、股票购买、重组或相关业务合并。它打算确定生命科学领域的商业机会。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMD)
- Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
- 3 Stable Growth Stocks for Bumpy Times
- Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
- The 2 Dow Stocks with Decade-Long Win Streaks on the Line
- Could Rite Aid Be an Acquisition Target, Again?
- 免费获取StockNews.com关于智能医学获取(IQMD)的研究报告
- 清洁能源法案通过后,太阳能股大放异彩
- 颠簸时代的3只稳定成长股
- 大型和小型石油和天然气类股盈利后反弹
- 连续十年上涨的两只道指股票
- Rite Aid会再次成为收购目标吗?
Want to see what other hedge funds are holding IQMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating).
想看看还有哪些对冲基金持有IQMD吗?访问HoldingsChannel.com获取智能医药收购公司(纳斯达克代码:iqmd-Get Rating)的最新13F备案文件和内幕交易信息。
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
接受《智能医药采购日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对智能医药收购和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧